[1] Vazquez ZGS, Klinger JR.Guidelines for the treatment of pulmonary arterial hypertension[J]. Lung, 2020 ,198(4):581-596. [2] Luna-López R, Ruiz Martín A, Escribano Subías P. Pulmonary arterial hypertension[J]. Med Clin (Barc),2022 ,158(12):622-629. [3] Poch D, Mandel J. Pulmonary Hypertension[J]. Ann Intern Med, 2021 ,174(4):ITC49-ITC64. [4] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35(11):979-987. [5] McQuillan BM, Picard MH, Leavitt M, et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects[J]. Circulation, 2001 ,104(23):2797-2802. [6] McGoon MD. The assessment of pulmonary hypertension[J]. Clin Chest Med,2001 ,22(3):493-508. [7] 杨杏,叶瑞华,周丽芹.肺动脉高压患者的病因构成与肺动脉压力因素[J].华夏医学,2020,33(4):67-70. [8] Bhatnagar A, Wiesen J, Dweik R, et al.Evaluating suspected pulmonary hypertension: A structured approach[J]. Cleve Clin J Med, 2018,85(6):468-480. [9] Barragan-Martinez MD, Cueto-Robledo G, Roldan-Valadez E, et al. A brief review on gender differences in mexican-mestizo patients with pulmonary arterial hypertension (PAH) at a tertiary-level hospital[J]. Curr Probl Cardiol, 2022 ,47(9):101275. [10] 李婧辰,张梅,李镒冲,等.我国40岁及以上人群慢性呼吸系统疾病症状流行现况及影响因素研究[J].中华流行病学杂志,2018,39(6):786-791. [11] Cheron C, McBride SA, Antigny F, et al. Sex and gender in pulmonary arterial hypertension[J]. Eur Respir Rev,2021,30(162):200330. [12] 张明娜,王秋月,侯刚,等.呼吸科肺动脉高压病因构成及肺动脉压力相关因素研究[J].中国实用内科杂志,2013,33(10):792-795. [13] 赵智东,付会文,崔利锋,等.NT-proBNP与凝血功能、动脉血气分析对慢性肺心病急性加重期患者判断价值分析[J].中国实验诊断学,2020,24(12):1934-1938. [14] 孙彦彦,卢甲,王卫平.心力衰竭合并肺动脉高压患者Gal-3、HMGB1及copeptin水平变化及临床意义[J].分子诊断与治疗杂志,2022,14(1):149-152. [15] 张舒婷,姚青青,李宜珊,等.慢性低氧性肺动脉高压大鼠动脉血气分析指标的变化及其意义[J].实验动物与比较医学,2021,41(1):27-32,54. [16] 赵艳菊,肖玉琴,王玲玲.动脉血气分析、凝血功能及肺动脉收缩压监测在慢性阻塞性肺疾病急性加重防治中的应用分析[J].实用医院临床杂志,2022,19(3):154-157. |